Innovex Sales Support For CVT Angina Drug Based On Percentage Formula
Executive Summary
Quintiles' contract sales division Innovex would receive up to one-third of the first two years of sales from a chronic stable angina treatment being developed by CV Therapeutics, under a commercialization deal announced May 11.